These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 300360)

  • 1. Immunoprotective activity of ribosomes from Haemophilus influenzae.
    Lynn M; Tewari RP; Solotorovsky M
    Infect Immun; 1977 Feb; 15(2):453-60. PubMed ID: 300360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.
    Tewari RP; Lynn M; Birnbaum AJ; Solotorovsky M
    Infect Immun; 1978 Jan; 19(1):58-65. PubMed ID: 304844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of immunogenic activity of ribosomal preparations from Haemophilus influenzae by various adjuvants.
    Cabrera-Contreras R; Plescia O; Solotorovsky M; Lynn M
    Vaccine; 1985 Jun; 3(2):103-8. PubMed ID: 3875945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum.
    Feit C; Tewari RP
    Infect Immun; 1974 Nov; 10(5):1091-7. PubMed ID: 16558095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological and biological activities of anti-Haemophilus influenzae ribosomal serum.
    Katz M; Lynn M; Solotorovsky M
    Infect Immun; 1981 Mar; 31(3):1125-31. PubMed ID: 6971811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of Haemophilus influenzae type B infection in normal and ribosome-immunized mice using intraperitoneal and intracerebral routes of inoculation.
    Burans JP; Kruszewski FH; Lynn M; Solotorovsky M
    Br J Exp Pathol; 1981 Oct; 62(5):496-503. PubMed ID: 6975113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of active immunity with membrane fractions from Haemophilus influenzae type b.
    Burans JP; Lynn M; Solotorovsky M
    Infect Immun; 1983 Jul; 41(1):285-93. PubMed ID: 6602769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions.
    Levy R; Segal E; Eylan E
    Infect Immun; 1981 Mar; 31(3):874-8. PubMed ID: 7014464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of mice to injection of ribosomal fraction from group B Neisseria meningitidis.
    Thomas DW; Weiss E
    Infect Immun; 1972 Sep; 6(3):355-63. PubMed ID: 4629260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of ribosomal preparations from Neisseria gonorrhoeae.
    Cooper MD; Tewari RP; Bowser DV
    Infect Immun; 1980 Apr; 28(1):92-100. PubMed ID: 6769823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acylated form of protein D of Haemophilus influenzae is more immunogenic than the nonacylated form and elicits an adjuvant effect when it is used as a carrier conjugated to polyribosyl ribitol phosphate.
    Akkoyunlu M; Melhus A; Capiau C; van Opstal O; Forsgren A
    Infect Immun; 1997 Dec; 65(12):5010-6. PubMed ID: 9393790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
    Johnson W
    Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
    Venneman MR; Bigley NJ
    J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring antibodies in human sera that react with Haemophilus influenzae type b ribosomal vaccine.
    Lynn M; Katz MA; Santucci TF
    J Clin Microbiol; 1983 May; 17(5):844-7. PubMed ID: 6602808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heat on antigenicity and immunogenicity of the antigenic determinant shared by Haemophilus influenzae type b and Escherichia coli K100.
    Whang HY; Goldhar J; Neter E
    Infect Immun; 1977 Oct; 18(1):68-72. PubMed ID: 71269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Haemophilus influenzae type b capsular antibody in neonatal rabbits by gastrointestinal colonization with cross-reacting Escherichia coli.
    Myerowitz RL; Handzel ZT; Scheerson R; Robbins JB
    Infect Immun; 1973 Feb; 7(2):137-40. PubMed ID: 4572607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations.
    Riottot M; Fournier JM; Pillot J
    Infect Immun; 1979 May; 24(2):476-82. PubMed ID: 378855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.
    Schneerson R; Robbins JB; Chu C; Sutton A; Vann W; Vickers JC; London WT; Curfman B; Hardegree MC; Shiloach J
    Infect Immun; 1984 Sep; 45(3):582-91. PubMed ID: 6332076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.
    Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI
    J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
    Schneerson R; Robbins JB
    N Engl J Med; 1975 May; 292(21):1093-6. PubMed ID: 48191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.